K Number
K172386
Device Name
1.8mm X 149cm Phoenix Atherectomy System, 2.2mm X 149cm Phoenix Atherectomy System, 2.4mm X 130cm Phoenix Atherectomy System
Date Cleared
2017-08-24

(16 days)

Product Code
Regulation Number
870.4875
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Phoenix Atherectomy System is intended for use in atherectomy of the peripheral vasculature. It is not intended for use in coronary, carotid, iliac or renal vasculature.
Device Description
The Phoenix Atherectomy System is a sterile, single-use device designed for atherectomy of the peripheral vasculature. The Phoenix Atherectomy System has two main components: the Phoenix Catheter and the Phoenix Handle. The Phoenix Catheter is a flexible, over-the-wire (OTW), front-cutting Catheter that continuously captures and clears debulked plaque proximally through the Catheter and Handle into a collection reservoir that resides outside the patient. For use, the Phoenix Catheter is inserted into the Phoenix Handle. The Handle incorporates a self-contained battery-powered motor designed to drive and rotate the cutter of the Phoenix Atherectomy Catheter at its specified rotational speed. The device is activated by an ON/OFF slider switch on the top of the Handle. A Wire Support Clip is used to hold a guidewire in a fixed position relative to the Handle and prevent guidewire rotation during the procedure. The Catheter, Handle, and Wire Support Clip are packaged as sterile, single-use components of the Phoenix Atherectomy System. There are multiple models of the Phoenix Catheter. The Phoenix Tracking Catheter models track directly over the guidewire with no tip deflection capability. These models are available in 1.8 mm and 2.2 mm tip diameter sizes; a 2.4 mm tip diameter size (identical in design to the currently marketed 2.4 mm Phoenix Deflecting Catheter) has been added under this 510(k). The controls for rotation are housed in the Phoenix Handle when the Catheter is inserted into the Handle. All Phoenix Catheter models are compatible with commercially available 0.014" exchange length (260 cm or greater) guidewires, and all use the same Phoenix Handle. This 510(k) includes modifications to the 1.8 mm and 2.2 mm tip diameter 149 cm Phoenix Tracking Catheter models to improve the overall catheter pushability and internal debris maceration of the longer length catheter models and (as just noted previously) to also add a 2.4 mm tip diameter 130 cm Phoenix Tracking Catheter to the Phoenix Catheter product family. Tables 9-1 and 9-2 summarize the subject modifications relative to the predicate devices.
More Information

No
The description focuses on mechanical and electrical components for atherectomy and does not mention any AI/ML capabilities or data processing for decision making.

Yes
The device is described as an "atherectomy system" intended for "atherectomy of the peripheral vasculature," which is a medical procedure to remove plaque from arteries to improve blood flow, thereby treating a medical condition.

No

This device is designed for atherectomy, which is a therapeutic procedure to remove plaque from blood vessels, not to diagnose a condition.

No

The device description clearly outlines physical components like a catheter, handle with a motor and battery, and a wire support clip. The performance studies also focus on physical characteristics and functional testing of these hardware components. There is no mention of software as a primary or standalone component.

Based on the provided information, the Phoenix Atherectomy System is not an In Vitro Diagnostic (IVD) device.

Here's why:

  • Intended Use: The intended use is "atherectomy of the peripheral vasculature." This is a surgical procedure performed in vivo (within the living body) to remove plaque from blood vessels.
  • Device Description: The description details a mechanical device with a catheter, handle, motor, and cutter designed to physically remove plaque from within the patient's blood vessels.
  • Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue, etc.) in vitro (outside the body) to provide information for diagnosis, monitoring, or screening.

IVD devices are used to perform tests on samples taken from the body, while the Phoenix Atherectomy System is used to directly treat a condition within the body.

N/A

Intended Use / Indications for Use

The Phoenix Atherectomy System is intended for use in atherectomy of the peripheral vasculature. It is not intended for use in coronary, carotid, iliac or renal vasculature.

Product codes

MCW

Device Description

The Phoenix Atherectomy System is a sterile, single-use device designed for atherectomy of the peripheral vasculature. The Phoenix Atherectomy System has two main components: the Phoenix Catheter and the Phoenix Handle.

The Phoenix Catheter is a flexible, over-the-wire (OTW), front-cutting Catheter that continuously captures and clears debulked plaque proximally through the Catheter and Handle into a collection reservoir that resides outside the patient. For use, the Phoenix Catheter is inserted into the Phoenix Handle. The Handle incorporates a self-contained battery-powered motor designed to drive and rotate the cutter of the Phoenix Atherectomy Catheter at its specified rotational speed. The device is activated by an ON/OFF slider switch on the top of the Handle. A Wire Support Clip is used to hold a guidewire in a fixed position relative to the Handle and prevent guidewire rotation during the procedure. The Catheter, Handle, and Wire Support Clip are packaged as sterile, single-use components of the Phoenix Atherectomy System.

There are multiple models of the Phoenix Catheter. The Phoenix Tracking Catheter models track directly over the guidewire with no tip deflection capability. These models are available in 1.8 mm and 2.2 mm tip diameter sizes; a 2.4 mm tip diameter size (identical in design to the currently marketed 2.4 mm Phoenix Deflecting Catheter) has been added under this 510(k). The controls for rotation are housed in the Phoenix Handle when the Catheter is inserted into the Handle. All Phoenix Catheter models are compatible with commercially available 0.014" exchange length (260 cm or greater) guidewires, and all use the same Phoenix Handle.

This 510(k) includes modifications to the 1.8 mm and 2.2 mm tip diameter 149 cm Phoenix Tracking Catheter models to improve the overall catheter pushability and internal debris maceration of the longer length catheter models and (as just noted previously) to also add a 2.4 mm tip diameter 130 cm Phoenix Tracking Catheter to the Phoenix Catheter product family.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

peripheral vasculature

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

To demonstrate the substantial equivalence of the modified Phoenix Atherectomy System to the predicate Phoenix Atherectomy System, the performance and technological characteristics were evaluated by completion of the following testing:

  • Dimensional and Visual Inspection .
  • Simulated Use
  • Cutter Torque Chain Torque-to-Failure Test
  • Functional Outer Shaft Torque Test
  • Knob to Shaft Testing
  • . Catheter Drive Train Stress Test
  • Cutter Stall Test
  • . Temperature Rise of Catheter During Simulated Use
  • Kink Bend Radius Test
  • Catheter Trackability in Below-the-Knee Anatomy ●
  • . Sheath Flow Rate (2.4mm X 130 cm Phoenix Catheter only)
  • Sheath Compatibility (2.4mm X 130 cm Phoenix Catheter only)

The results from this testing demonstrate that the performance and technological characteristics of the modified Phoenix Atherectomy System meet pre-defined design requirements and that the modified Phoenix Atherectomy System performs in a manner equivalent to the predicate Phoenix Atherectomy System with the identical intended use.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K140944

Reference Device(s)

K143328

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 870.4875 Intraluminal artery stripper.

(a)
Identification. An intraluminal artery stripper is a device used to perform an endarterectomy (removal of plaque deposits from arterisclerotic arteries.)(b)
Classification. Class II (performance standards).

0

Image /page/0/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, stacked on top of each other.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

August 24, 2017

Volcano AtheroMed, Inc. Ms. Jean Chang Senior Director. Operations 1530 O'Brien Drive. Suite A Menlo Park, California 94025

Re: K172386

Trade/Device Name: Phoenix Atherectomy System Regulation Number: 21 CFR 870.4875 Regulation Name: Intraluminal Artery Stripper Regulatory Class: Class II Product Code: MCW Dated: August 7, 2017 Received: August 8, 2017

Dear Ms. Chang:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device

1

related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education (DICE) at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education (DICE) at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely,

Kenneth J. Cavanaugh -S

for

Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K172386

Device Name Phoenix Atherectomy System

Indications for Use (Describe)

The Phoenix Atherectomy System is intended for use in atherectomy of the peripheral vasculature. It is not intended for use in coronary, carotid, iliac or renal vasculature.

Type of Use (Select one or both, as applicable)
---------------------------------------------------

X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

510(k) Summary

Submitter Information:

Date of 510(k) Summary Preparation:August 22, 2017
Name and Address of Manufacturer:Volcano AtheroMed, Inc.
1530 O'Brien Drive, Suite A.
Menlo Park, CA 94025
Contact Person:Jean Chang
Sr Director, Operations
Phone: (916) 281-2937

Subject Device:

Device Trade Name:Phoenix® Atherectomy System
Common Name:Peripheral Atherectomy Catheter
Regulation Description:Intraluminal Artery Stripper
Regulation Number:21 CFR 870.4875
Product Code:MCW
Device Class:Class II
Classification Panel:Cardiovascular

Predicate Device:

Trade Name: 510(k) Numbers: Manufacturer:

Phoenix Atherectomy System Primary: Secondary: K140944 Volcano AtheroMed, Inc.

4

Device Description:

The Phoenix Atherectomy System is a sterile, single-use device designed for atherectomy of the peripheral vasculature. The Phoenix Atherectomy System has two main components: the Phoenix Catheter and the Phoenix Handle.

The Phoenix Catheter is a flexible, over-the-wire (OTW), front-cutting Catheter that continuously captures and clears debulked plaque proximally through the Catheter and Handle into a collection reservoir that resides outside the patient. For use, the Phoenix Catheter is inserted into the Phoenix Handle. The Handle incorporates a self-contained battery-powered motor designed to drive and rotate the cutter of the Phoenix Atherectomy Catheter at its specified rotational speed. The device is activated by an ON/OFF slider switch on the top of the Handle. A Wire Support Clip is used to hold a guidewire in a fixed position relative to the Handle and prevent guidewire rotation during the procedure. The Catheter, Handle, and Wire Support Clip are packaged as sterile, single-use components of the Phoenix Atherectomy System.

There are multiple models of the Phoenix Catheter. The Phoenix Tracking Catheter models track directly over the guidewire with no tip deflection capability. These models are available in 1.8 mm and 2.2 mm tip diameter sizes; a 2.4 mm tip diameter size (identical in design to the currently marketed 2.4 mm Phoenix Deflecting Catheter) has been added under this 510(k). The controls for rotation are housed in the Phoenix Handle when the Catheter is inserted into the Handle. All Phoenix Catheter models are compatible with commercially available 0.014" exchange length (260 cm or greater) guidewires, and all use the same Phoenix Handle.

This 510(k) includes modifications to the 1.8 mm and 2.2 mm tip diameter 149 cm Phoenix Tracking Catheter models to improve the overall catheter pushability and internal debris maceration of the longer length catheter models and (as just noted previously) to also add a 2.4 mm tip diameter 130 cm Phoenix Tracking Catheter to the Phoenix Catheter product family. Tables 9-1 and 9-2 summarize the subject modifications relative to the predicate devices.

Indications for Use:

The Phoenix® Atherectomy System is intended for use in atherectomy of the peripheral vasculature. It is not intended for use in coronary, carotid, iliac or renal vasculature.

Testing Summary:

To demonstrate the substantial equivalence of the modified Phoenix Atherectomy System to the predicate Phoenix Atherectomy System, the performance and technological characteristics were evaluated by completion of the following testing:

5

  • Dimensional and Visual Inspection .
  • Simulated Use
  • Cutter Torque Chain Torque-to-Failure Test
  • Functional Outer Shaft Torque Test
  • Knob to Shaft Testing
  • . Catheter Drive Train Stress Test
  • Cutter Stall Test
  • . Temperature Rise of Catheter During Simulated Use
  • Kink Bend Radius Test
  • Catheter Trackability in Below-the-Knee Anatomy ●
  • . Sheath Flow Rate (2.4mm X 130 cm Phoenix Catheter only)
  • Sheath Compatibility (2.4mm X 130 cm Phoenix Catheter only)

The results from this testing demonstrate that the performance and technological characteristics of the modified Phoenix Atherectomy System meet pre-defined design requirements and that the modified Phoenix Atherectomy System performs in a manner equivalent to the predicate Phoenix Atherectomy System with the identical intended use.

6

Table 9-1: Technological Characteristics Comparison Summary of the Predicate to the Modified
130 cm Phoenix Atherectomy System
Technological
CharacteristicPredicate Phoenix Atherectomy System
(K140944),
5F (FG1847) and 6F (FG1984) Phoenix
CathetersModified Phoenix
Atherectomy System,
(Subject Device),
7F (FG2938)
Rotational Speed10,000-12,000 RPMIdentical
Guidewire ExchangeOver-the-wireIdentical
Guidewire Compatibility0.014"Identical
Sheath Compatibility5F - 6F7F
Catheter Working Length130 cmIdentical
Catheter Torque ShaftMulti-Strand Stainless Steel (SS)Identical
Catheter Outer ShaftStainless Steel Outer Shaft and Teflon
sheathIdentical
Catheter Shaft Diameter1.7mmIdentical
Distal Cutter Flute Maximum
Diameter1.8 mm (FG1847)
2.2 mm (FG1984)2.4 mm
Tip Diameter and Crossing
Profile1.8 mm (FG1847)
2.2 mm (FG1984)2.4 mm
Cutting Tip PortSingle exit port conveys excised debris from
the inner guidewire lumen into the Distal
Cutting Flute channelIdentical
Second Stage Maceration
within HousingYesYes
Cutter HousingNo CoatingIdentical
Distal Tip Assembly CoatingDLC CoatingIdentical
Minimum Vessel Size for
Device Use2.5 mm (FG1847)
3.0 mm (FG1984)Identical to FG1984 (3.0 mm)
Debris Collection & RemovalContinuous collection and removal of
excised debris by mechanical conveyanceIdentical
Steering (Directional)
mechanismRotation of knob on handle steers distal tip
and cutter by torqueing catheter shaftIdentical
Catheter CoatingNoIdentical
SterilizationEthylene OxideIdentical
Single-use onlyYesIdentical

7

| Table 9-2: Technological Characteristics Comparison Summary of the Predicate to the Modified

149 cm Phoenix Atherectomy System
Technological
CharacteristicPredicate Phoenix Atherectomy
System (K143328),
5F (FG2160) and 6F (FG2162)
Phoenix CathetersModified Phoenix Atherectomy
System, (Subject Device),
5F (FG2160) and 6F (FG2162)
Phoenix Catheters)
Rotational Speed10,000-12,000 RPMIdentical
Guidewire ExchangeOver-the-wireIdentical
Guidewire Compatibility0.014"Identical
Sheath Compatibility5F - 6FIdentical
Catheter Working Length149 cmIdentical
Catheter Torque ShaftMulti-Strand Stainless Steel (SS)Identical
Catheter Outer ShaftStainless Steel Outer Shaft and
Teflon sheathIdentical with Modified Flexibility
along shaft
Catheter Shaft Diameter1.7 mmIdentical
Distal Cutter Flute Maximum
Diameter1.8 mm (FG2160)
2.2 mm (FG2162)Identical (FG2160)
Identical (FG2162)
Tip Diameter and Crossing
Profile1.8 mm (FG2160)
2.2 mm (FG2162)Identical (FG2160)
Identical (FG2162)
Cutting Tip PortSingle exit port conveys excised
debris from the inner guidewire
lumen into the Distal Cutting Flute
channelIdentical
Second Stage Maceration within
HousingYesYes
(modified to further optimize internal
maceration)
Cutter HousingNo CoatingIdentical
Distal Tip Assembly CoatingDLC CoatingIdentical
Minimum Vessel Size for Device
Use2.5 mm (FG2160)
3.0 mm (FG2162)Identical (FG2160)
Identical (FG2162)
Debris Collection & RemovalContinuous collection and removal
of excised debris by mechanical
conveyanceIdentical
Steering (Directional)
mechanismRotation of knob on handle steers
distal tip and cutter by torqueing
catheter shaftIdentical
Catheter CoatingNoIdentical
SterilizationEthylene OxideIdentical
Single-use onlyYesIdentical